Dawn Stephenson

Dawn Stephenson is an experienced professional in regulatory affairs, currently serving as the Director of Regulatory Affairs at ClinChoice since January 2024. With a strong background in pharmaceutical sciences and project management, Dawn has held various leadership roles, including Director of Regulatory Affairs & CMC at TG Therapeutics, Inc., and Director of Regulatory Affairs in Oncology at Amgen. Prior experience includes leadership positions at PPD, Grünenthal, UCB, and Pfizer, where Dawn managed global regulatory teams and provided strategic guidance throughout product development. Dawn holds a BSc (Hons) in Chemical and Pharmaceutical Science from the University of Sunderland.